ID

31595

Descripción

SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00773318

Link

https://clinicaltrials.gov/show/NCT00773318

Palabras clave

Versiones (1)
  1. 10/9/18 10/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00773318

Inglés

Eligibility Prostate Cancer NCT00773318

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically proven prostate cancer
Descripción

Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
initial staging (bone scan, ct, or mri) according to the nccn guidelines
Descripción

TNM clinical staging | Bone scan | CT | MRI

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C0203668
UMLS CUI [3]
C0040405
UMLS CUI [4]
C0024485
patients with ajcc stages i - ii - iii prostate cancer including men with clinical t3n0m0 disease, men with psa > 10 mg/ml, and men with gleason score of 8-10 (high grade disease)
Descripción

Prostate carcinoma TNM clinical staging | Gender | Disease TNM clinical staging | Prostate specific antigen measurement | Disease High grade Gleason score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0079399
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C3258246
UMLS CUI [4]
C0201544
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C0205082
UMLS CUI [5,3]
C3203027
prostate cancer patients will be scheduled for prostatectomy and pelvic lymph node dissection
Descripción

Prostate carcinoma | Prostatectomy Scheduled | Pelvic lymphadenectomy Scheduled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0033573
UMLS CUI [2,2]
C0205539
UMLS CUI [3,1]
C0193883
UMLS CUI [3,2]
C0205539
informed consent signed by the patient
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with no histological evidence of prostate cancer
Descripción

Prostate carcinoma Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332197
patient with regionally advanced disease or metastatic disease (t4, and/or n1, and/or m1)
Descripción

Advanced disease regional TNM clinical staging | Neoplasm Metastasis TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679246
UMLS CUI [1,2]
C0205147
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C3258246
patients with clinically and/or radiologically evident regional lymph node metastases
Descripción

Secondary malignant neoplasm of lymph node regional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686619
UMLS CUI [1,2]
C0205147
patients who are not scheduled for radical prostatectomy and pelvic lymph node dissection
Descripción

Absence Radical prostatectomy Scheduled | Absence Pelvic lymphadenectomy Scheduled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0194810
UMLS CUI [1,3]
C0205539
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0193883
UMLS CUI [2,3]
C0205539
patients with physical and/or psychological contraindications
Descripción

Medical contraindication Physical | Medical contraindication Psychological

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0205485
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0205486
recent studies in nuclear medicine with long half-time isotopes (i.e. t ½ > 48h; 111in, 67ga, 201tl, 131i) performed within 1 week preceding the lm/sl
Descripción

Nuclear Medicine (radioisotope study) | Other Coding | Indium-111 | Gallium-67 | Thallium-201 | iodine I-131

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1547109
UMLS CUI [2]
C3846158
UMLS CUI [3]
C0303403
UMLS CUI [4]
C0303225
UMLS CUI [5]
C0303322
UMLS CUI [6]
C0303029
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00773318

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma
Item
patients with histologically proven prostate cancer
boolean
C0600139 (UMLS CUI [1])
TNM clinical staging | Bone scan | CT | MRI
Item
initial staging (bone scan, ct, or mri) according to the nccn guidelines
boolean
C3258246 (UMLS CUI [1])
C0203668 (UMLS CUI [2])
C0040405 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
Prostate carcinoma TNM clinical staging | Gender | Disease TNM clinical staging | Prostate specific antigen measurement | Disease High grade Gleason score
Item
patients with ajcc stages i - ii - iii prostate cancer including men with clinical t3n0m0 disease, men with psa > 10 mg/ml, and men with gleason score of 8-10 (high grade disease)
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C0012634 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
C0201544 (UMLS CUI [4])
C0012634 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C3203027 (UMLS CUI [5,3])
Prostate carcinoma | Prostatectomy Scheduled | Pelvic lymphadenectomy Scheduled
Item
prostate cancer patients will be scheduled for prostatectomy and pelvic lymph node dissection
boolean
C0600139 (UMLS CUI [1])
C0033573 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
C0193883 (UMLS CUI [3,1])
C0205539 (UMLS CUI [3,2])
Informed Consent
Item
informed consent signed by the patient
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prostate carcinoma Absent
Item
patients with no histological evidence of prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Advanced disease regional TNM clinical staging | Neoplasm Metastasis TNM clinical staging
Item
patient with regionally advanced disease or metastatic disease (t4, and/or n1, and/or m1)
boolean
C0679246 (UMLS CUI [1,1])
C0205147 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Secondary malignant neoplasm of lymph node regional
Item
patients with clinically and/or radiologically evident regional lymph node metastases
boolean
C0686619 (UMLS CUI [1,1])
C0205147 (UMLS CUI [1,2])
Absence Radical prostatectomy Scheduled | Absence Pelvic lymphadenectomy Scheduled
Item
patients who are not scheduled for radical prostatectomy and pelvic lymph node dissection
boolean
C0332197 (UMLS CUI [1,1])
C0194810 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0193883 (UMLS CUI [2,2])
C0205539 (UMLS CUI [2,3])
Medical contraindication Physical | Medical contraindication Psychological
Item
patients with physical and/or psychological contraindications
boolean
C1301624 (UMLS CUI [1,1])
C0205485 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0205486 (UMLS CUI [2,2])
Nuclear Medicine (radioisotope study) | Other Coding | Indium-111 | Gallium-67 | Thallium-201 | iodine I-131
Item
recent studies in nuclear medicine with long half-time isotopes (i.e. t ½ > 48h; 111in, 67ga, 201tl, 131i) performed within 1 week preceding the lm/sl
boolean
C1547109 (UMLS CUI [1])
C3846158 (UMLS CUI [2])
C0303403 (UMLS CUI [3])
C0303225 (UMLS CUI [4])
C0303322 (UMLS CUI [5])
C0303029 (UMLS CUI [6])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial